Intracept by Boston Scientific

Relievant Medsystems, Inc., founded in 2006 and headquartered in the United States, is a leading medical device company in the biotechnology and healthcare industries, with offices in Minneapolis, MN, and Sunnyvale, CA. The company focuses on developing innovative solutions to enhance the quality of life for millions of patients suffering from chronic vertebrogenic low back pain. Its flagship product, the Intracept® System, is a minimally invasive procedure that delivers targeted energy into the spine, effectively blocking the transmission of pain signals from the basivertebral nerve. This pioneering approach provides spine surgeons and interventional spine physicians with a clinically proven method for long-lasting pain relief. The company recently secured a substantial $50.00M Series G investment on 27th March 2023, attracting support from prominent investors including New Enterprise Associates, Canaan Partners, Lightstone Ventures, Morgenthaler Ventures, Ally Bridge Group, Endeavour Vision, and Vensana Capital. This sizable investment underscores strong investor confidence in Relievant Medsystems' innovative technology and its potential to revolutionize the treatment of chronic vertebrogenic low back pain, addressing a significant unmet medical need in the healthcare market. With its compelling value proposition and support from reputable investors, Relievant Medsystems is well-positioned for growth and continued impact in the healthcare industry.